Q2 2017 13F Holders as of 30 Jun 2017
-
Type / Class
-
Equity / ADR
-
Shares outstanding
-
55,574,229
-
Total 13F shares
-
23,269,447
-
Share change
-
+2,743,010
-
Total reported value
-
$646,000,000
-
Price per share
-
$27.76
-
Number of holders
-
34
-
Value change
-
+$76,066,932
-
Number of buys
-
21
-
Number of sells
-
15
Institutional Holders of Ascendis Pharma A/S - ADR (ASND) as of Q2 2017
As of 30 Jun 2017 Ascendis Pharma A/S - ADR (ASND) had 34 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 23,269,447 shares of stock of the company.
Largest 10 holders included RA CAPITAL MANAGEMENT, LLC, ORBIMED ADVISORS LLC, FMR LLC, Vivo Capital, LLC, BAKER BROS. ADVISORS LP, EcoR1 Capital, LLC, venBio Select Advisor LLC, VHCP Management II, LLC, ACUTA CAPITAL PARTNERS, LLC, and EVENTIDE ASSET MANAGEMENT, LLC.
This table shows 34 institutional shareholders of the security as of 30 Jun 2017.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.